Warfarin treatment outcomes in children monitored at home with a point-of-care device

Thrombosis and Haemostasis

Volumn 105, Issue 6, 2011, Pages 1103-1105

  Biss, Tina T ^a   Avery, Peter J ^b   Walsh, Patricia M ^c   Kamali, Farhad ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; WARFARIN;

ADOLESCENT; AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ARTERIAL TRUNK; BLEEDING; BRAIN ISCHEMIA; CARDIOMYOPATHY; CHILD; CHILD CARE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DISEASE DURATION; EPISTAXIS; FEMALE; FONTAN PROCEDURE; HEMATEMESIS; HOME MONITORING; HUMAN; INFANT; INTERNATIONAL NORMALIZED RATIO; LETTER; MALE; MEDICAL RECORD REVIEW; MENORRHAGIA; MUSCLE HEMATOMA; ONSET AGE; PATENT DUCTUS ARTERIOSUS; POINT OF CARE TESTING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; STROKE; THROMBOEMBOLISM; THROMBOSIS; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; FEMALE; FONTAN PROCEDURE; HUMANS; INFANT; MALE; POINT-OF-CARE SYSTEMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; THROMBOSIS; TRICUSPID ATRESIA; WARFARIN;

EID: 79958141927     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-09-0608     Document Type: Letter

References (12)

1. Streif W, Andrew M, Marzinotto V, et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999; 94: 3007-3014.
2. Black KL, Bauman ME, Kuhle S, et al. Warfarin therapy induced coagulopathy in children: assessment of a conservative approach. J Thromb Haemost 2009; 7 (Suppl1): OC-TU-066 (Abstract).
3. Massicotte P, Julian JA, Gent M, et al. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res 2003; 109: 85-92.
4. Newall F, Campbell J, Savoia H, et al. Incidence of major bleeding in a large paediatric cohort of patients requiring warfarin therapy. J Thromb Haemost 2005; 3 (Suppl1): OR357 (Abstract).
5. Newall F, Savoia H, Campbell J, et al. Anticoagulation clinics for children achieve improved warfarin management. Thromb Res 2004; 114: 5-9.
6. Bradbury MJ, Taylor G, Short P, et al. A comparative study of anticoagulant control in patients on longterm warfarin using home and hospital monitoring of the international normalised ratio. Arch Dis Child 2008; 93: 303-306.
7. Newall F, Monagle P & Johnston L. Home INR monitoring of oral anticoagulant therapy in children using the Coaguchek™S point-of-care monitor and a robust education program. Thromb Res 2006; 118: 587-593.
8. Bhat D, Upponi A, Rakecha A, et al. Evaluating safety, effectiveness, and user satisfaction of home international normalized ratio monitoring service: Experience from a tertiary pediatric cardiology unit in the United Kingdom. Pediatr Cardiol 2010; 31: 18-21.
9. Bauman ME, Black KL, Massicotte MP et al. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin. Thromb Haemost 2008; 99: 1097-1103.
10. Marzinotto V, Monagle P, Chan A, et al. Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting. Pediatr Cardiol 2000; 21: 347-352.
11. Greenway A, Ignjatovic V, Summerhayes R, et al. Point-of-care monitoring of oral anticoagulant therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95). Thromb Haemost 2009; 102: 159-165.
12. Bauman ME, Black K & Kuhle S. KIDCLOT©: The importance of validated educational intervention for optimal long term warfarin management in children. Thromb Res 2009; 123: 707-709.